Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Gut bacteria may hold key to slowing memory loss

NCT ID NCT07226674

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how natural compounds in fruits and vegetables (called flavonoids) are broken down by gut bacteria and whether those breakdown products help protect the brain. Researchers will give 100 adults aged 50+ at risk for Alzheimer's a special diet and measure changes in their gut microbes, blood, and thinking skills. The goal is to understand the connection between diet, gut health, and memory.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Nov 2025

An estimate. Start dates often move.

Expected to finish

Jan 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 50+ years * BMI ≥ 25 kg/m2 * Enhanced risk of AD - defined as family history of AD, 1st degree family member * Habitually consume suboptimal diets such as typical Western diet (i.e., high in animal products, refined carbohydrates and processed food). * Subjects capable of and willing to comply with the protocol and to give their written informed consent. Exclusion Criteria: * Cognitive impairment at time of recruitment into the study, as measured by the Mini Mental Status Exam (MMSE, score 25-30), and Clinical Dementia Rating (CDR, score=0) or Everyday Cognition Scale-12 (ECog-12, score\<1.36 included). * Pre-existing psychosis or psychiatric conditions. * Currently receiving treatment for dementia. * History of substance abuse or cerebrovascular events. * Heavy use of tobacco (\>1/2 pack per day) * Any intolerance or allergy documented or suspected to one of the components of the study products. * Have taken probiotics or antibiotic therapy within the last 1 month * Change in medication use in the last 3 months. * Frailty, malnutrition, or food allergy/intolerance requiring special diets will also be excluded. * Following any specific diet (vegetarian, vegan, etc.) * Body weight at enrolment greater than 400lbs due to weight restrictions on the MRI table. * Pregnant, breastfeeding, postpartum for less than 6 months, or unwilling to practice birth control during participation in the study. * Unable to safely participate in the MRI (claustrophobia, presence of devices affected by MRI such as pacemakers, neurostimulators, or metallic foreign body, etc.) * Chronic pain. * Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data. * Having a psychological or linguistic inability to sign the informed consent; * Under legal protection (guardianship, wardship) or deprived from his rights following administrative or judicial decision; * Subject participating in another biomedical study or participation in another study within the 3 months before entry into this study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cognitive decline are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Ulster University, Human Intervention Studies Unit

    RECRUITING

    Coleraine, BT52 1SA, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.